Please assess the completion status of the following clinical trial:

Trial Title: Comparing Acular LS and Pred Forte in Reducing Post-selective Laser Trabeculoplasty Anterior Chamber Flare and Cells

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosed with open angle glaucoma patients at the Rocky Mountain Lions Eye Institute Glaucoma Clinic.~* Able to provide written informed consent to participate.~* Must be the age of 18 years of age or older.~* Patients in which further intraocular pressure lowering by selective laser trabeculoplasty is necessary in the opinion of the treating physician.~Exclusion Criteria:~* Patients with eye surgery in the prior six months.~* Patients with prior or current use of topical or systemic corticosteroids or NSAIDs.~* Patients with pre-existing anterior chamber inflammation.~* Patients with known sensitivity to any of the study medications.~* Due to the age range and the disease entity, special patient populations such as children or pregnant women will not be enrolled in this study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Acular LS (Type: ACTIVE_COMPARATOR): Acular LS - 1 drop in treated eye, 4 times a day, for 4 days
- Pred Forte (Type: ACTIVE_COMPARATOR): Pred Forte - 1 drop in treated eye, 4 times a day, for 4 days
- Refresh Tears (Type: PLACEBO_COMPARATOR): Refresh Tears - 1 drop in treated eye, 4 times a day, for 4 days

Based on this trial design, predict the completion outcome and termination type (if applicable).